Pan-Canadian Pharmaceutical Alliance
Tracked across 3 events · 18 articles · First seen Jul 06, 2026 · Last active Sep 01, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: pCPA negotiated and signed the LOI with Vertex, facilitating potential public reimbursement for ALYFTREK in Canada.
Jul 06, 2026 · 6 articles
Regulatory
Impact: The alliance will negotiate pricing for Leqembi, which will determine the final reimbursement terms and market access.
Sep 01, 2026 · 6 articles
Domestic
Impact: The alliance's pricing negotiations in July 2026 enabled Canada — Saskatchewan to offer Alyftrek at a publicly funded price, supporting cost-effective access.
Aug 04, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Pan-Canadian Pharmaceutical Alliance live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard